Charles Zhou

Stock Analyst at UBS

(0.17)
# 2669
Out of 5,352 analysts
13
Total ratings
42.86%
Success rate
-6.97%
Average return
8 Stocks
Name Action PT Current % Upside Ratings Updated
FUTU Futu Hldgs
Maintains: Strong Buy
130 136
104.97 29.56% 3 Mar 17, 2025
ZYME Zymeworks
Reiterates: Buy
16
12.08 32.45% 1 Mar 8, 2023
COGT Cogent Biosciences
Initiates Coverage On: Buy
15
5.78 159.52% 1 Jun 28, 2022
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 May 5, 2022
PMVP PMV Pharma
Initiates Coverage On: Buy
56
0.9 6122.22% 1 Aug 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
1.45 3072.41% 1 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 3 Aug 25, 2017